schliessen

Filtern

 

Bibliotheken

Re: Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2015.12.011 Byline: M. Pilar Laguna

Journal Title: The Journal of urology March 2016, Vol.195(3), pp.608
Main Author: Laguna, M Pilar
Format: Electronic Article Electronic Article
Language: English
Subjects:
ID: E-ISSN: 1527-3792 ; PMID: 26887702 Version:1 ; DOI: 10.1016/j.juro.2015.12.011
Link: http://pubmed.gov/26887702
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: medline26887702
title: Re: Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2
format: Article
creator:
  • Laguna, M Pilar
subjects:
  • Health Care Costs
  • Registries
  • Angiogenesis Inhibitors -- Economics
  • Antineoplastic Agents -- Economics
  • Carcinoma, Renal Cell -- Economics
  • Immunologic Factors -- Economics
  • Kidney Neoplasms -- Economics
  • Protein Kinase Inhibitors -- Economics
ispartof: The Journal of urology, March 2016, Vol.195(3), pp.608
description: To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2015.12.011 Byline: M. Pilar Laguna
language: eng
source:
identifier: E-ISSN: 1527-3792 ; PMID: 26887702 Version:1 ; DOI: 10.1016/j.juro.2015.12.011
fulltext: fulltext
issn:
  • 15273792
  • 1527-3792
url: Link


@attributes
ID348433908
RANK0.07
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
LOCALfalse
PrimoNMBib
record
control
sourcerecordid26887702
sourceidmedline
recordidTN_medline26887702
sourceformatXML
sourcesystemOther
pqid1767068714
galeid456439736
display
typearticle
titleRe: Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2
creatorLaguna, M Pilar
ispartofThe Journal of urology, March 2016, Vol.195(3), pp.608
identifier
subjectHealth Care Costs ; Registries ; Angiogenesis Inhibitors -- Economics ; Antineoplastic Agents -- Economics ; Carcinoma, Renal Cell -- Economics ; Immunologic Factors -- Economics ; Kidney Neoplasms -- Economics ; Protein Kinase Inhibitors -- Economics
languageeng
source
descriptionTo link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.juro.2015.12.011 Byline: M. Pilar Laguna
version6
lds50peer_reviewed
links
openurl$$Topenurl_article
backlink$$Uhttp://pubmed.gov/26887702$$EView_this_record_in_MEDLINE/PubMed
openurlfulltext$$Topenurlfull_article
addlink$$Uhttp://exlibris-pub.s3.amazonaws.com/aboutMedline.html$$EView_the_MEDLINE/PubMed_Copyright_Statement
search
creatorcontribLaguna, M Pilar
titleRe: Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2
subject
0Health Care Costs
1Registries
2Angiogenesis Inhibitors -- Economics
3Antineoplastic Agents -- Economics
4Carcinoma, Renal Cell -- Economics
5Immunologic Factors -- Economics
6Kidney Neoplasms -- Economics
7Protein Kinase Inhibitors -- Economics
general
026887702
1English
2MEDLINE/PubMed (U.S. National Library of Medicine)
310.1016/j.juro.2015.12.011
4MEDLINE/PubMed (NLM)
sourceidmedline
recordidmedline26887702
issn
015273792
11527-3792
rsrctypearticle
creationdate2016
addtitleThe Journal of urology
searchscope
0medline
1nlm_medline
2MEDLINE
scope
0medline
1nlm_medline
2MEDLINE
lsr41201603
citationpf 608 vol 195 issue 3
startdate20160301
enddate20160331
lsr30VSR-Enriched:[pqid, description, issn, galeid]
sort
titleRe: Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2
authorLaguna, M Pilar
creationdate20160300
lso0120160300
facets
frbrgroupid9010466888891037849
frbrtype5
newrecords20190701
languageeng
creationdate2016
topic
0Health Care Costs
1Registries
2Angiogenesis Inhibitors–Economics
3Antineoplastic Agents–Economics
4Carcinoma, Renal Cell–Economics
5Immunologic Factors–Economics
6Kidney Neoplasms–Economics
7Protein Kinase Inhibitors–Economics
collectionMEDLINE/PubMed (NLM)
prefilterarticles
rsrctypearticles
creatorcontribLaguna, M Pilar
jtitleJournal Of Urology
toplevelpeer_reviewed
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
aulastLaguna
aufirstM Pilar
auLaguna, M Pilar
atitleRe: Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2
jtitleThe Journal of urology
risdate201603
volume195
issue3
spage608
pages608
eissn1527-3792
formatjournal
genrearticle
ristypeJOUR
doi10.1016/j.juro.2015.12.011
pmid26887702
issn00225347
oafree_for_read
date2016-03